Opinion|Videos|July 29, 2024
Navigating 2L Treatment Strategies with Oral SERDs and Elasestrant
A panel of experts discuss navigating 2L treatment strategies.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are your perceptions on efficacy and safety data on PROTAC
ASCO 2024 #TPS1131 TACTIVE-K: Phase 1b/2 study of vepdegestrant plus CDK4i PF-07220060
- What are your perceptions on efficacy and safety data on SERM:
- Lasoxifene:
ASCO 2024 #TPS1127 : Phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib
- Lasoxifene:
- How do these options compare? Why might you choose one of these options vs fulvestrant?
Advertisement
Related to this article
Matthew P. Goetz, MD, explores first-line treatment selection, emerging targeted therapies, and unmet sequencing needs in metastatic breast cancer.
Readers share their opinions on some of the most talked-about breast cancer abstracts they’re looking forward to seeing at ESMO 2026.
The top 5 OncLive TV videos of the week.
The liquid biopsy identifies ESR1 mutations in blood to select patients with metastatic breast cancer who may be eligible for treatment with camizestrant.
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
China's approval of Dato-DXd for TNBC was supported by TROPION-Breast02 data showing a median OS of 23.7 months vs 18.7 months with chemotherapy.
Check out this September recap of OncLive’s coverage of the top news and expert insights in breast cancer.
Here is your cheat sheet to all therapeutic options that were cleared by the FDA in September 2026 spanning tumor types.
Advertisement
Advertisement
Trending on OncLive
1
Dr Fradley on Real-World Atrial Fibrillation and Cardiovascular Outcomes in CLL
2
Poll Results Highlight Breast Cancer Abstracts of Interest at ESMO 2026
3
FDA Grants Fast Track Designation to Opamtistomig for Advanced Biliary Tract Cancer
4
Dr Hansen on the Integration of CAR T-Cell Therapy Into Earlier Myeloma Treatment Lines
5